CFTR structure: lassoing cystic fibrosis
Crossref DOI link: https://doi.org/10.1038/nsmb.3353
Published Online: 2017-01-05
Published Print: 2017-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ford, Bob
Text and Data Mining valid from 2017-01-01
Article History
First Online: 5 January 2017
Competing interests
: B.F. consulted in 2015 and 2016 for Vertex, Inc., which discovered and currently markets ivacaftor.